Aarti Drugs Ltd — Quarterly Results & Earnings

₹319.75

-3.05%

Profit Growth YoY29.33%Latest quarter

Sales Growth YoY9.10%Latest quarter

Sales CAGR 5Y5.74%5 year compound

Profit CAGR 5Y4.03%5 year compound

📋

Quarterly Performance

YoY Profit Growth+29.33%

🔥 Exceptional growth

YoY Sales Growth+9.10%

📈 Moderate growth

OPM 5Y Average

Operating profit margin

13.80%

EPS Growth 5Y

4.46%

Interest Coverage

Higher = safer debt servicing

7.77

ROE

12.69%

ROCE

13.09%

💡

Growth Analysis

Aarti Drugs Ltd reported YoY profit growth of 29.33% and revenue growth of 9.10% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 5.74% and profits at 4.03% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Aarti Drugs Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.